{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:20:14Z","timestamp":1767144014182,"version":"build-2238731810"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.atherosclerosis.2024.117609","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T07:15:11Z","timestamp":1717139711000},"page":"117609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Skin autofluorescence, a measure for accumulation of advanced glycation end products, positively associates with blood neutrophil and monocyte counts in the general population, and particularly in men with prediabetes"],"prefix":"10.1016","volume":"395","author":[{"given":"Anouk G.","family":"Groenen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedek","family":"Halmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle A.","family":"van Zeventer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas B.","family":"Salzbrunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne L.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita D.","family":"La Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilja M.","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Jacob","family":"Schuringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerwin","family":"Huls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2230-1659","authenticated-orcid":false,"given":"Marit","family":"Westerterp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.117609_bib1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2337\/diacare.15.9.1156","article-title":"Pathogenesis of the atherosclerotic lesions. Implications for diabetes mellitus","volume":"15","author":"Schwartz","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib2","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis. Epidemiology, Pathophysiology, and Management","volume":"287","author":"Beckman","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"34","author":"Basta","year":"2004","journal-title":"Cardiovasulcar Res."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/diab.43.6.836","article-title":"Glycation and diabetic complications","volume":"43","author":"Brownlee","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: Sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/geronj\/45.4.B105","article-title":"Nonenzymatic glycosylation, the Maillard reaction and the aging process","volume":"45","author":"Monnier","year":"1990","journal-title":"J. Gerontol."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM198602133140702","article-title":"Relation between complications of Type I diabetes mellitus and collagen-linked fluorescence","volume":"314","author":"Monnier","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1755-6686.2008.00038.x","article-title":"Advanced glycation end products in renal failure: an overview","volume":"34","author":"Noordzij","year":"2008","journal-title":"J. Ren. Care"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/eci.12627","article-title":"Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study","volume":"46","author":"van Waateringe","year":"2016","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib10","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1196\/annals.1333.036","article-title":"Simple noninvasive measurement of skin autofluorescence","volume":"1043","author":"Meerwaldt","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib12","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.2337\/dc05-2173","article-title":"Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes","volume":"29","author":"Lutgers","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/dia.2009.0113","article-title":"Reference values of skin autofluorescence","volume":"12","author":"Koetsier","year":"2010","journal-title":"Diabetes Technol. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-020-00676-4","article-title":"Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes","volume":"21","author":"Boersma","year":"2021","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2337\/dc06-1391","article-title":"Skin autofluorescence is a strong predictor of cardiac mortality in diabetes","volume":"30","author":"Meerwaldt","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00125-018-4769-x","article-title":"Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population","volume":"62","author":"van Waateringe","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dc07-1755","article-title":"Skin Autofluorescence A tool to identify type 2 diabetic patients at risk for developing microvascular complications","volume":"31","author":"Gerrits","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib18","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/dme.12005","article-title":"Skin autofluorescence and risk of micro- and macrovascular complications in patients with type 2 diabetes mellitus - a multi-centre study","volume":"29","author":"Noordzij","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1464-5491.2011.03448.x","article-title":"Skin autofluorescence is associated with severity of vascular complications in Japanese patients with type 2 diabetes","volume":"29","author":"Tanaka","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00125-022-05821-3","article-title":"Advanced glycation end-products, cardiac function and heart failure in the general population: the Rotterdam Study","volume":"66","author":"Arshi","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the Resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.ATV.0000156877.94472.a5","article-title":"Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to Intervene?","volume":"25","author":"Coller","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib23","first-page":"1","article-title":"Neutrophil counts and cardiovascular disease","volume":"00","author":"Luo","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib24","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/dyu229","article-title":"Cohort Profile: LifeLines, a three-generation cohort study and biobank","volume":"44","author":"Scholtens","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2022.01.008","article-title":"Large HDL particles negatively associate with leukocyte counts independent of cholesterol efflux capacity: a cross sectional study in the population-based LifeLines DEEP cohort","volume":"343","author":"Groenen","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib26","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1097\/HS9.0000000000000470","article-title":"The association between anemia and skin autofluorescence, a marker for advanced glycation end product accumulation","volume":"4","author":"Wouters","year":"2020","journal-title":"Hemasphere"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jama.2023.4063","article-title":"Diagnosis and Management of prediabetes: a Review","volume":"329","author":"Echouffo-Tcheugui","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib28","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1182\/bloodadvances.2021006755","article-title":"Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals","volume":"6","author":"Van Zeventer","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/dia.2009.0113","article-title":"Reference values of skin autofluorescence","volume":"12","author":"Koetsier","year":"2010","journal-title":"Diabetes Technol. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib30","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib31","article-title":"RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism","volume":"5","author":"Senatus","year":"2020","journal-title":"J. Clin. Investigat. Insight"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109980","article-title":"Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes","volume":"190","author":"Neves","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib34","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/CIR.0000000000000343","article-title":"Sex differences in the cardiovascular consequences of diabetes mellitus. A scientific statement from the American Heart Association","volume":"132","author":"Regensteiner","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00125-019-4939-5","article-title":"Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course","volume":"62","author":"Huebschmann","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib36","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/ATVBAHA.118.310945","article-title":"Association of Total and differential leukocyte counts with cardiovascular disease and mortality in the UK biobank","volume":"38","author":"Welsh","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib37","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1093\/eurheartj\/ehad649","article-title":"Neutrophil counts and cardiovascular disease","volume":"44","author":"Luo","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib38","doi-asserted-by":"crossref","first-page":"m2297","DOI":"10.1136\/bmj.m2297","article-title":"Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis","volume":"370","author":"Cai","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/dia.2010.0014","article-title":"Skin autofluorescence and glycemic variability","volume":"12","author":"Noordzij","year":"2010","journal-title":"Diabetes Technol. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","article-title":"The neutrophil\u2013lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials","volume":"42","author":"Adamstein","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/dia.2009.0113","article-title":"Reference values of skin autofluorescence","volume":"12","author":"Koetsier","year":"2010","journal-title":"Diabetes Technol. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib43","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/db07-1808","article-title":"Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes","volume":"57","author":"Soro-Paavonen","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib44","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/eurheartj\/eht402","article-title":"Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype","volume":"35","author":"Hanssen","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib45","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/srt.12471","article-title":"Gender differences in the fluorescence of human skin in young healthy adults","volume":"24","author":"Morvov\u00e1","year":"2018","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/derm.26046","article-title":"Ethnic and gender differences in advanced glycation end products measured by skin auto-fluorescence","volume":"5","author":"Mook-Kanamori","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep10198","article-title":"A new gender-specific model for skin autofluorescence risk stratification","volume":"5","author":"Ahmad","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0185175","article-title":"Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus","volume":"12","author":"Ahmad","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2024.117609_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/postgradmedj-2016-134579","article-title":"Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations","volume":"93","author":"Da Moura Semedo","year":"2017","journal-title":"Postgrad. Med."}],"updated-by":[{"DOI":"10.1016\/j.atherosclerosis.2025.119164","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024001692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024001692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:27:59Z","timestamp":1762187279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024001692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":49,"alternative-id":["S0021915024001692"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117609","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin autofluorescence, a measure for accumulation of advanced glycation end products, positively associates with blood neutrophil and monocyte counts in the general population, and particularly in men with prediabetes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117609"}}